Enhanced bacterial uptake and bactericidal properties of ofloxacin loaded on bioadhesive hydrogels against Pseudomonas aeruginosa

Journal of Chemotherapy

Volumn 22, Issue 5, 2010, Pages 328-334

  Romero, V L ^a   Manzo, R H ^a   Alovero, Fabiana L ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Bacterial uptake; Bactericidal index; Bactericidal profiles; Bioahesive hydrogels; Carbomer; Fluoroquinolones

Indexed keywords

CARBOMER; CIPROFLOXACIN; GLYCINE; LEVOFLOXACIN; NORFLOXACIN; OFLOXACIN;

ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG POTENCY; DRUG RELEASE; DRUG UPTAKE; FLOW KINETICS; HYDROGEL; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH; PSEUDOMONAS AERUGINOSA; VISCOSITY;

EID: 78651405897     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/joc.2010.22.5.328     Document Type: Article

References (29)

1. Van Bambeke F, Michot J-M, Van Eldere J, Tulkens PM. Quinolones in 2005: an update. Clin Microbiol Infect 2005;11: 256-280.
2. Bertino JS (Jr) Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clinical Ophthalmol 2009; 3: 507-521
3. Kowalski RP, Dhaliwal DK, Karenchak LM, Romanowski E, Mah F, Ritterband D et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 2003; 136: 500-505.
4. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: New weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002; 133: 463-466.
5. Mamalis N. The increasing problem of antibiotic resistance. J Cataract Refract Surg 2007; 33: 1831-1832
6. Moshirfar M, Mirzaian G, Feiz V, Kang PC. Fourth-generation fluoroquinolone- resistant bacterial keratitis after refractive surgery. J Cataract Refract Surg 2006; 32: 515-518.
7. Food and Drug Administration. Department of Health and Human Services. USA. Access: December 2008. Available from: http://www.fda.gov/OHRMS/DOCKETS/ 98fr/E8-20938.htm
8. European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). UK. Access: august 2008. Available from: http://www.emea.europa.eu/ pdfs/human/press/pr/38292708en.pdf
9. Khalil H, Chen T, Riffon R, Wang R, Wang Z. Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2008; 52: 1635-1641.
10. Bernkkop-Schnürch A (Theme Editor). Preface mucoadhesive polymers: strategies, achievements and future challenges. Adv Drug Deliv Rev 2005; 57:1553-1555.
11. Chickering III D E, Mathiowitz E. Definitions, mechanisms and theories of bioadhesion. In: Mathiowitz E, Chickering III D, Lehr C-M, eds. Bioadhesive Drug Delivery Systems. New York: Marcel Dekker, Inc. 1999; 1-11.
12. Tamburic S, Craig DQM. An investigation into the rheological, dielectric and bioadhesive properties of poly (acrylic acid) gel systems. J Controlled Rel 1995; 37: 59-68.
13. Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Advanced Drug Delivery Reviews 2005; 57: 1595-1639
14. Vilches AP, Jimenez-Kairuz AF, Alovero FL, Olivera ME, Allemandi DA, Manzo RH. Release kinetics and uptake studies of model fluoroquinolones from carbomer hydrogels. Int J Pharm 2002; 246: 17-24.
15. Jimenez-Kairuz AF, Allemandi DA, Manzo RH. The improvement of aqueous chemical stability of a model basic drug by ion pairing with acid groups of poly electrolytes. Int J Pharm 2004; 269: 149-156
16. Esteban SL, Manzo RH, Alovero FL. Azithromycin loaded on hydrogels of carbomer. Chemical stability and delivery properties. Int J Pharm 2009; 366: 53-57.
17. th ed. London: Pharmaceutical Press. 2006; 111-115.
18. th edition - approved standard. CLSI publication M7-A7. Wayne, PA: 2006.
19. Morrisey I. Bactericidal Index: a new way to assess quinolone bactericidal activity in vitro. J Antimicrob Chemother 1997; 39: 713-717
20. Chapman JS, Georgopapadakou; NH. Fluorometric assay for fleroxacin accumulation by bacterial cells. Antimicrob Agents Chemother 1989; 33: 27-29.
21. Alovero FL, Nieto MJ, Mazzieri MR, Then R, Manzo RH. Mode of action of sulfanilyl fluoroquinolones. Antimicrob Agents Chemother 1998; 42: 1495-1498
22. Morrisey I, George JT. Bactericidal activity of gemifloxacin and other quinolones against Streptococcus pneumoniae. J Antimicrob Chemother 2000; 45: 107-110.
23. Pendland SL, Neuhauser MM, Garey KW, Prause JL, Jung R. Comparative killing rates of gatifloxacin and ciprofloxacin against 14 clinical isolates: impact of bacterial strain and antibiotic concentration. Diagn Microbiol Infect Dis 2002; 44: 59-61
24. Fung-Tomc JC, Gradelski E, Valera L, Kolek B, Bonner DP. Comparative killing rates of fluoroquinolones and cell wall-active agents. Antimicrob Agents Chemother 2000; 44: 1377-1380.
25. Fresta M, Guccione S, Beccari AR, Furneri PM, Puglisi, G. Combining molecular modelling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin. Bioorg Med Chem 2002; 10: 3871-3889.
26. Chapman JS, Georgopapadakou NH. Routes of Quinolone Permeation in Escherichia coli. Antimicrob Agents Chemother 1988; 32: 438-442.
27. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 2003; 51: 1109-1117.
28. Asuquo A E, Piddock, LJV. Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother 1993; 31: 865-880.
29. Caramella CM, Rossi S, Bonferoni MC. A rheological approach to explain the mucoadhesive behavior of polymer hydrogels. In Mathiowitz E, Chickering III D, Lehr C-M, eds. Bioadhesive Drug Delivery Systems. New York: Marcel Dekker, Inc. 1999; 25-65